Avista Pharma Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 330

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 3

Avista Pharma General Information

Description

Provider of contract development, manufacturing, and testing services of newly created medicinal drugs. The company offers a broad suite of scientifically differentiated services ranging from early-stage discovery, API and Drug Product development and cGMP manufacturing to stand-alone analytical and microbiology testing support of medicines.

Contact Information

Formerly Known As
Microtest Labs
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • Durham, NC
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avista Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avista Pharma‘s full profile, request access.

Request a free trial

Avista Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of contract development, manufacturing, and testing services of newly created medicinal drugs. The company offe
Drug Discovery
Durham, NC
330 As of 2019
00000 0000-00-00
000000&0

000000

am, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo cons
000000000000000
Toronto, Canada
000 As of 0000
000.00 0000-00-00
000000&0

000000

ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
000000000000000
San Diego, CA
00 As of 0000
00.00
000.00 0000-00-00
000000&0 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avista Pharma Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dalton Pharma Services Corporate Backed or Acquired Toronto, Canada 000 000000&0
IriSys (Pharmaceuticals) Formerly VC-backed San Diego, CA 00 00.00 000000&0 00.00
MedPharm Private Equity-Backed Guildford, United Kingdom 000 000000000
Capsugel Formerly PE-Backed Morristown, NJ 0000 00000 000000&0 00000
Jubilant Pharmova Corporation Noida, India 0000 00000 00000000000 00000
You’re viewing 5 of 28 competitors. Get the full list »

Avista Pharma Patents

Avista Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11591339-B2 Solid forms of (r)-n-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[ 1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1h-carbazol-3-amine maleate as aryl hydrocarbon receptor (ahr) inhibitors Active 26-Nov-2019 0000000000 00
US-20210253579-A1 Polymorphic compounds and uses thereof Active 26-Nov-2019 0000000000
EP-3917932-A1 Chemical compounds Inactive 30-Jan-2019 0000000000
EP-3917932-A4 Chemical compounds Inactive 30-Jan-2019 0000000000 0
EP-3917935-A1 Synthetic process and novel intermediates Inactive 30-Jan-2019 C07D487/04
To view Avista Pharma’s complete patent history, request access »

Avista Pharma Executive Team (6)

Name Title Board Seat Contact Info
Eric Evans Chief Financial Officer
Ken Domagalski Chief Operating Officer of CMC Operations
You’re viewing 2 of 6 executive team members. Get the full list »

Avista Pharma Board Members (3)

Name Representing Role Since
00000 000000 Ampersand Capital Partners Board Member 000 0000
0000 000000 00.0 Avista Pharma Board Member 000 0000
000000 000000000 Ampersand Capital Partners Board Member 000 0000
To view Avista Pharma’s complete board members history, request access »

Avista Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avista Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Avista Pharma‘s full profile, request access.

Request a free trial

Avista Pharma Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Solid Form Solutions 23-Jan-2018 0000000000 Biotechnology 0000000 0
Accuratus Lab Services 07-Aug-2015 0000000000 Laboratory Services (Healthcare)
Scynexis (Contract Services Business) 23-Jul-2015 Merger/Acquisition Pharmaceuticals 0000000 0
To view Avista Pharma’s complete acquisitions history, request access »

Avista Pharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Accuratus Lab Services 07-Aug-2015 000000000000000000 Completed
  • 000000 000000
To view Avista Pharma’s complete exits history, request access »

Avista Pharma FAQs

  • When was Avista Pharma founded?

    Avista Pharma was founded in 2015.

  • Where is Avista Pharma headquartered?

    Avista Pharma is headquartered in Durham, NC.

  • What is the size of Avista Pharma?

    Avista Pharma has 330 total employees.

  • What industry is Avista Pharma in?

    Avista Pharma’s primary industry is Drug Discovery.

  • Is Avista Pharma a private or public company?

    Avista Pharma is a Private company.

  • What is the current valuation of Avista Pharma?

    The current valuation of Avista Pharma is 00000.

  • What is Avista Pharma’s current revenue?

    The current revenue for Avista Pharma is 000000.

  • Who are Avista Pharma’s investors?

    Accuratus Lab Services and Array BioPharma have invested in Avista Pharma.

  • Who are Avista Pharma’s competitors?

    Dalton Pharma Services, IriSys (Pharmaceuticals), MedPharm, Capsugel, and Jubilant Pharmova are some of the 28 competitors of Avista Pharma.

  • When was Avista Pharma acquired?

    Avista Pharma was acquired on 02-Jan-2019.

  • Who acquired Avista Pharma?

    Avista Pharma was acquired by Cambrex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »